NGS, personalized medicine and early cancer detection are driving adoption, creating opportunities in liquid biopsy, precision oncology, drug development and recurring consumables.Dublin, Sept. (GLOBE ...

A new discovery by neuroscientists at Brown University's Carney Institute for Brain Science challenges long-held beliefs in ...

"Our study provides, to our knowledge, the first direct biochemical evidence that folded G-quadruplex structures are present ...

Many people are surprised to learn that 3 to 5 percent of cancer patients receive a diagnosis of Cancer of Unknown Primary (CUP)1—where the tumor primary origin cannot be found. Liquid biopsy is ...

Spain has installed its first 3D spatial transcriptomics platform at CNAG in Barcelona. This breakthrough allows researchers to study gene activity in real tissue environments. The first project ...

A $2.9 million R01 research award from the National Institutes of Health will support the efforts of engineers at the UC Santa Cruz Genomics Institute to further develop and drive down the cost of ...

Can we predict who will respond to cancer immunotherapy before treatment starts? Explore PD-L1, TMB, MSI, TLS, T-cell states, ...

Demand is rising for automated, cost-effective nucleic acid extraction, driven by sequencing, PCR diagnostics, precision medicine, genomics R&D and disease testing.Dublin, Sept. 15, 2026 (GLOBE ...

Scientists have long believed that large stretches of our genetic material, known as long noncoding RNAs (lncRNAs), help ...

A mouse-sized bat that lives for decades appears to have evolved some of the same biological protections that help it resist ...

The authors highlight three potential regulators - galectin 1, galectin 3, and Myc - providing solid evidence for potential roles in modulating the proliferation of cochlear GER cells using gene ...

Finally, AI is being used for something good for a change.AI is on everyone's minds right now. If you're not working with it ...